Olga Visternichan

Olga Visternichan

Auto-generated profile, based on publicly available information

Olga Visternichan

Department of Internal Diseases, Karaganda Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
PAPanagiotis Evaggelos Antoniou
Panagiotis Evaggelos Antoniou
EDEleni Dafli
Eleni Dafli
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
GIGaukhar Igimbayeva
Gaukhar Igimbayeva
OVOlga Visternichan
Olga Visternichan
PANAGIOTIS BAMIDISPANAGIOTIS BAMIDIS
PANAGIOTIS BAMIDIS
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a leading cause of mortality and morbidity. Patient knowledge about AF and its management is paramount but often limited. Patients need to be appropriately informed about treatment options, medicinal adherence, and potential consequences of nonadherence, while also understanding treatment goals and expectations from it. Mobile health apps have experienced an explosion both in their availability and acceptance as “soft interventions” for patient engagement and education; however, the prolific nature of such solutions revealed a gap in the evidence base regarding their efficacy and impact. Virtual patients (VPs), interactive computer simulations, have been used as learning activities in modern health care education. VPs demonstrably improved cognitive and behavioral skills; hence, they have been effectively implemented across undergraduate and postgraduate curricula. However, their application in patient education has been rather limited so far. Objective: This work aims to implement and evaluate the efficacy of a mobile-deployed VP regimen for the education and engagement of patients with AF on crucial topics regarding their condition. A mobile VP app is being developed with the goal of each VP being a simple scenario with a set goal and very specific messages and will be subsequently attempted and evaluated. Methods: A mobile VP player app is being developed so as to be used for the design of 3 educational scenarios for AF management. A pseudorandomized controlled trial for the efficacy of VPs is planned to be executed at 3 sites in Greece, Ukraine, and Kazakhstan for patients with AF. The Welch t test will be used to demonstrate the performance of patients’ evaluation of the VP experience. Results: Our study is at the development stage. A preliminary study regarding the system’s development and feasibility was initiated in December 2022. The results of our study are expected to be available in 2024 or when the needed sample size is achieved. Conclusions: This study aims to evaluate and demonstrate the first significant evidence for the value of VP resources in outreach and training endeavors for empowering and patients with AF and fostering healthy habits among them. International Registered Report Identifier (IRRID): PRR1-10.2196/45946

2 January 2020 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
DTDana Zhumagaliyevna Taizhanova
Dana Zhumagaliyevna Taizhanova
RBRoza Bodaubay
Roza Bodaubay
ATAliya Toleuova
Aliya Toleuova
AKAkerke Kalimbetova
Akerke Kalimbetova
DBDmitriy D Babenko
Dmitriy D Babenko
OVOlga Visternichan
Olga Visternichan
BACKGROUND: There is a reason to believe that the polymorphism of genes encoding some enzymes and receptors plays a role in increasing of restenosis development risk. It is common knowledge that ethnicity affects the frequency of heterozygous genotypes occurrence. There is the evidence that polymorphism of the FGB gene (rs1800790) and THBD gene was determined in the ethnic group of Kazakhs with restenosis of the coronary arteries, which can be considered as genetic predictors of restenosis development. Today, the questions of the role of the genetic component in the development of coronary heart disease (CHD) remain open. AIM: Evaluation of gene polymorphism in patients with restenosis of coronary arteries after stent installation. MATERIALS AND METHODS: The group consisted of Kazakh population of the age category from 45 to 65 years of both sexes: Group I (50 persons) patients with a diagnosis of CHD, with a fixed stent and the development of restenosis during the year; Group 2 (58 persons) – with a fixed stent and no restenosis during the year. The association of genetic polymorphisms was evaluated in accordance with the case–control design based on the generalized linear model assuming a log-additive inheritance model. RESULTS: Thus, when comparing two groups using five patterns of inheritance, the following SNP were revealed: Codominant inheritance pattern – rs1045642 (p = 0.0427), dominant inheritance pattern – rs12041331 (p = 0.036088), rs13431554 (p = 0.025461), and rs1045642 (p = 0.012774), and overdominant inheritance pattern – rs12041331 (p = 0.051736), rs5918 (p = 0.057652), and rs13431554 (р = 0.036006). Thus, three SNPs associated with stenting were identified: rs7543130 (p = 0.009324), rs6785930 (p = 0.016858), and rs7819412 (p = 0.061325) and two SNPs associated with the development of restenosis after stent placement: rs1061781 (p = 0.063184) and rs342293 (p = 0.061636). CONCLUSION: The polymorphisms associated with the risk of developing restenosis after stenting were determined: Codominant inheritance pattern – one polymorphism (rs1045642, p = 0.0427); dominant inheritance pattern – three polymorphisms (rs12041331, p = 0.036088; rs13431554, p = 0.025461; rs1045642, p = 0.012774), and overdominant inheritance pattern – one polymorphism (rs13431554, p = 0.036006). Based on the hybrid machine learning approach (RuleFit), four rules were obtained for assessing the empirical risk of restenosis developing after stenting – from 20% to 40%.

30 January 2023 in JMIR Preprints
Verified
Preprint
Open access
PAPanagiotis Evaggelos Antoniou
Panagiotis Evaggelos Antoniou
EDEleni Dafli
Eleni Dafli
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
GIGaukhar Igimbayeva
Gaukhar Igimbayeva
OVOlga Visternichan
Olga Visternichan
PANAGIOTIS BAMIDISPANAGIOTIS BAMIDIS
PANAGIOTIS BAMIDIS
BACKGROUND Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a leading cause of mortality and morbidity. Patient knowledge about AF and its management is paramount but often limited. Patients need to be appropriately informed about treatment options, medicinal adherence, and potential consequences of nonadherence, while also understanding treatment goals and expectations from it. Mobile health apps have experienced an explosion both in their availability and acceptance as “soft interventions” for patient engagement and education; however, the prolific nature of such solutions revealed a gap in the evidence base regarding their efficacy and impact. Virtual patients (VPs), interactive computer simulations, have been used as learning activities in modern health care education. VPs demonstrably improved cognitive and behavioral skills; hence, they have been effectively implemented across undergraduate and postgraduate curricula. However, their application in patient education has been rather limited so far. OBJECTIVE This work aims to implement and evaluate the efficacy of a mobile-deployed VP regimen for the education and engagement of patients with AF on crucial topics regarding their condition. A mobile VP app is being developed with the goal of each VP being a simple scenario with a set goal and very specific messages and will be subsequently attempted and evaluated. METHODS A mobile VP player app is being developed so as to be used for the design of 3 educational scenarios for AF management. A pseudorandomized controlled trial for the efficacy of VPs is planned to be executed at 3 sites in Greece, Ukraine, and Kazakhstan for patients with AF. The Welch t test will be used to demonstrate the performance of patients’ evaluation of the VP experience. RESULTS Our study is at the development stage. A preliminary study regarding the system’s development and feasibility was initiated in December 2022. The results of our study are expected to be available in 2024 or when the needed sample size is achieved. CONCLUSIONS This study aims to evaluate and demonstrate the first significant evidence for the value of VP resources in outreach and training endeavors for empowering and patients with AF and fostering healthy habits among them. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/45946

28 December 2025 in Kardiologiia
Verified
Journal Article
Closed access
ASA. N. Seitekova
A. N. Seitekova
OPO. A. Ponamareva
O. A. Ponamareva
VMV. B. Molotov-Luchanskiy
V. B. Molotov-Luchanskiy
OVO. A. Visternichan
O. A. Visternichan
GMG. Zh. Mershenova
G. Zh. Mershenova
NMN. B. Myrzashova
N. B. Myrzashova
Aim   Evaluation of epicardial fat thickness (EFT) and concentrations of biochemical markers in overweight patients after coronary artery bypass grafting (CABG) at different stages of the rehabilitation period. Material and methods The study included 155 patients aged 35 to 65 years with left main coronary artery disease who underwent CABG. Patients were divided into 3 groups. The main group (Group 1) consisted of 85 overweight (OW) patients (48 men and 37 women) after CABG (CABG+OW+) with body mass index (BMI) 28.0 ± 0.9 kg/m2). Group 2 included 70 patients (39 men and 31 women) with normal body weight (BMI 23.3 ± 1.1 kg/m2) after CABG (CABG+OW–). The control group (Group 3) consisted of 30 healthy age-matched volunteers without acute or chronic disease (BMI 20.4±0.7 kg/m2). Results A trend toward increased EFT and concentrations of acid-soluble blood fraction (ASBF) and deoxyribonucleic acid (DNA) in blood was observed in Group 1 at the third stage of rehabilitation. Concentrations of neutrophil extracellular traps (NETs) were significantly (p<0.05) higher in Group 1 at all stages of rehabilitation, with a trend toward an increase at the third stage of rehabilitation compared to Group 2. Conclusion In OW patients after CABG, the EFT and the DNA concentration were significantly increased 1.8 times (p<0.05), the ASFB was 2.1 times higher, and the NET concentration was 1.9 times higher than in patients with normal body weight. In OW patients after CABG, the EFT and the concentrations of cell-free nucleic acids (ASBF, DNA) and NETs were significantly increased (p<0.05) at the third stage of rehabilitation compared to patients with normal body weight. Strong direct correlations were found between EFT and ASBF (r=0.705; p<0.001) at the second stage of rehabilitation and between EFT and DNA (r=0.825; p<0.001) at the third stage of rehabilitation.

30 November 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ASAizhan Seitekova
Aizhan Seitekova
VMV. B. Molotov-­lUchansky
V. B. Molotov-­lUchansky
OPOlga Ponamareva
Olga Ponamareva
GMG. Zh. Mershenova
G. Zh. Mershenova
BEB. T. Ekizhanova
B. T. Ekizhanova
АДА. С. Дильдабекова
А. С. Дильдабекова
Aim . To study the purine metabolism changes in overweight patients who underwent coronary artery bypass grafting (CABG) in the early postoperative period and during the rehabilitation, compared with that in patients with normal body weight. Material and methods . This prospective study included 155 patients, including 87 (56%) men and 68 (44%) women, who underwent CABG due to critical coronary artery stenosis. All patients were diagnosed with single-­vessel disease. The age range was 35-65 years. Patients we­re divided into 3 following groups: group 1 (n=85) — overweight pa­tients; group 2 (n=70) — patients with normal body weight; group 3 (con­trol group) — 30 healthy individuals. Changes in purine metabolite le­vels were assessed over time: 1 day after blood flow restoration at the cardiac surgery center, and then at rehabilitation stages 1 (1 to 3 months), 2 (3 to 6 months), and 3 (6 months to 1 year) at the cardiac re­ha­bi­lita­tion center. Statistical analysis was performed using SPSS 27.0 and MedCalc version 22 software. The data are presented as tables and graphs using GraphPad PrismTM (version 7). Results . In overweight patients after CABG, purine metabolite levels initially decrease, including in rehabilitation stages 1 and 2, and then sharply increase in rehabilitation stage 3. Conclusion . In overweight patients, the level of purine metabolites in­creases sharply after CABG at rehabilitation stage 3 compared to those at stages 1 and 2, suggesting resumption of the pathological process (ischemia, inflammation).